Bain Capital Specialty Finance, Inc. Cash & Equivalents History
BCSF|5 years of SEC 10-K data (FY2021-FY2025)
$23M in FY2025 with a 3-year CAGR of -8.6%.
Declined from $43M to $23M over the past 2 years.
Declined from $43M to $23M over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
- 3-Year CAGR
- -8.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Cash & Equivalents Trend
Key Insights
- 3-year CAGR of -8.6%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 55.2% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
Annual Data
| Year | Cash & Equivalents | YoY Growth |
|---|---|---|
| FY2025 | $23.1M | -55.2% |
| FY2024 | $51.6M | +19.9% |
| FY2023 | $43.0M | +42.3% |
| FY2022 | $30.2M | -65.5% |
| FY2021 | $87.4M | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026